Recombinant high density lipoprotein reconstituted with apolipoprotein AI cysteine mutants as delivery vehicles for 10-hydroxycamptothecin
- PMID: 20579804
- DOI: 10.1016/j.canlet.2010.05.023
Recombinant high density lipoprotein reconstituted with apolipoprotein AI cysteine mutants as delivery vehicles for 10-hydroxycamptothecin
Abstract
10-Hydroxycamptothecin (HCPT) is an effective anticancer agent whose therapeutic potential is limited by poor water-solubility and selectivity, short half-life and side effects. It has been shown that high density lipoprotein (HDL) or recombinant HDL (rHDL) reconstituted with wide-type apolipoprotein AI (apoAIwt) is an effective drug delivery model because of its specific structural characteristics and the targeted receptor-mediated uptake mechanism. In this study, the apoAI(Milano) (apoAI(M)) mutant with higher receptor affinity was chosen as a potential delivery vehicle from seven cysteine mutants of apoAI constructed by our laboratory. rHDL-HCPT nanoparticles reconstituted with apoAI(M), named as rHDL(M)-HCPT, seemed to be primarily spherical model with mean diameter were 22.39±10.25nm, which is similar with the diameter of natural HDL. rHDL(M)-HCPT showed a very steady sustained release pattern in vitro and increased the drug concentration in major organs, relative to free HCPT. Furthermore, in comparison with free HCPT, rHDL(M)-HCPT nanoparticles increased the cytotoxicity of HCPT by 70 and 50 times in SKOV-3 and HCT-116 cells. The data presented in this study indicate that rHDL(M) reconstituted with apoAI(M) could be exploited as a potential delivery vehicle of HCPT with controlled release, enhanced tissue distribution and higher cytotoxicity.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Delivery of hydrophilic drug doxorubicin hydrochloride-targeted liver using apoAI as carrier.J Drug Target. 2013 May;21(4):367-74. doi: 10.3109/1061186X.2012.757769. Epub 2013 Apr 19. J Drug Target. 2013. PMID: 23600747
-
Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin.Int J Nanomedicine. 2016 Nov 22;11:6229-6238. doi: 10.2147/IJN.S112835. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27920529 Free PMC article.
-
Cholesterol mobilization by free and lipid-bound apoAI(Milano) and apoAI(Milano)-apoAII heterodimers.Biochemistry. 2001 Mar 27;40(12):3666-73. doi: 10.1021/bi002141j. Biochemistry. 2001. PMID: 11297434
-
Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research.Molecules. 2019 Aug 2;24(15):2829. doi: 10.3390/molecules24152829. Molecules. 2019. PMID: 31382521 Free PMC article. Review.
-
High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.ACS Nano. 2016 Mar 22;10(3):3015-41. doi: 10.1021/acsnano.5b07522. Epub 2016 Feb 25. ACS Nano. 2016. PMID: 26889958 Free PMC article. Review.
Cited by
-
Recombinant high-density lipoprotein nanoparticles containing gadolinium-labeled cholesterol for morphologic and functional magnetic resonance imaging of the liver.Int J Nanomedicine. 2012;7:3751-68. doi: 10.2147/IJN.S33139. Epub 2012 Jul 17. Int J Nanomedicine. 2012. PMID: 22888232 Free PMC article.
-
A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation.Int J Nanomedicine. 2016 Jun 23;11:2979-94. doi: 10.2147/IJN.S102726. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27382284 Free PMC article.
-
Reconfiguring Nature's Cholesterol Accepting Lipoproteins as Nanoparticle Platforms for Transport and Delivery of Therapeutic and Imaging Agents.Nanomaterials (Basel). 2020 May 8;10(5):906. doi: 10.3390/nano10050906. Nanomaterials (Basel). 2020. PMID: 32397159 Free PMC article. Review.
-
High-Density Lipoproteins for Therapeutic Delivery Systems.J Mater Chem B. 2016 Jan 14;4(2):188-197. doi: 10.1039/C5TB01332A. Epub 2015 Nov 24. J Mater Chem B. 2016. PMID: 27069624 Free PMC article.
-
Fatty acids as therapeutic auxiliaries for oral and parenteral formulations.Adv Drug Deliv Rev. 2013 Oct;65(10):1331-9. doi: 10.1016/j.addr.2012.07.012. Epub 2012 Aug 17. Adv Drug Deliv Rev. 2013. PMID: 22921839 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources